Di Nuzzo Private Wealth, Inc. Bridge Bio Pharma, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 30 shares of BBIO stock, worth $1,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 25
20.0%
Holding current value
$1,859
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.15 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.02 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$822 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$772 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$575 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.19B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...